EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Expenditure on Infant Formula, Brand Decisions and Misleading Marketing in the UK: Inequitable Impacts Upon Low‐Income Families

Amy Brown, Charlotte Walker, Aimee Grant, Sally Etheridge, Sabine Goodwin, Catrin Griffiths, Sara Jones, Holly Morse, Rhiannon Phillips, Rosalind Sharpe, Victoria Thomas, Victoria Sibson

Maternal & Child Nutrition · 2026-10 · 22 (4)

DOI: 10.1111/mcn.70296 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Infant formula brands in the United Kingdom (UK) differ significantly in cost despite no evidence of preferential impacts upon infant health and development. This mixed methods study explored the factors that drive higher spending on formula milk, comparing this for families who were struggling to afford formula milk or not. UK parents with a baby aged 0–12 months who use infant formula completed an online survey ( n = 478). Additionally, 20 parents who were struggling to afford infant formula taking part in interviews. Expenditure and brand decisions were compared for those struggling to afford infant formula and eligible for financial support ( n = 94), struggling but not eligible for support ( n = 167) and not struggling to afford infant formula ( n = 217). There was no significant difference in weekly amount spent between the three groups. Two thirds of parents chose higher‐cost brands although mothers who were mixed feeding were less likely to buy a higher‐cost milk than those exclusively formula feeding. Parents who were struggling to afford formula were more likely to buy a brand due to perceived better‐quality/additional ingredients and because it was supplied in hospital and perceived to have healthcare professional endorsement than those who were not struggling. Qualitative analysis showed that parents bought higher‐cost brands in case future research showed an impact, from fear of judgement, worries around brand availability, and perceptions that brands were closest to breast milk. Stronger regulation is needed of misleading marketing of breastmilk substitutes alongside ensuring availability and accessibility of lower‐cost products.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →